EMEA-002402-PIP02-18

Key facts

Active substance
Artesunate
Therapeutic area
Infectious diseases
Decision number
P/0423/2019
PIP number
EMEA-002402-PIP02-18
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of severe malaria caused by Plasmodium falciparum
Route(s) of administration
Intravenous use
Contact for public enquiries
ACE Pharmaceuticals B.V.

Tel. +31 365227201
E-mail: ace@ace-pharm.nl

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating